Tramadol versus methadone for treatment of opiate withdrawal: A double-blind, randomized, clinical trial

Journal of Addictive Diseases

Volumn 31, Issue 2, 2012, Pages 112-117

  Zarghami, Mehran ^a   Masoum, Babak ^a   Shiran, Mohammad Reza ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methadone; opioid; tramadol; withdrawal

Indexed keywords

METHADONE; OPIATE; TRAMADOL;

ADULT; ARTICLE; ATAXIA; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG SCREENING; DRUG SUBSTITUTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PAIN; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SOMNOLENCE; SWEATING; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TRAMADOL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861327444     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2012.665728     Document Type: Article

References (31)

1. Iranian National Drug Control Headquarters. http://dchq.ir/html/index. php? newlang=eng (accessed August 15, 2011
2. Stotts AL, CL Dodrill, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009; 10:1727-40.
3. Lobmaier P, Gossop M, Waal H, Bramness J. The pharmacological treatment of opioid addiction-a clinical perspective. Eur J Clin Pharmacol 2010; 66:537-45.
4. Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 2011; 30:155-66.
5. Guthrie SK. Pharmacologic interventions for the treatment of opioid dependence and withdrawal. Dicp 1990; 24:721-34.
6. Wilcock A, Beattie JM. ProlongedQT interval and methadone: implications for palliative care. Curr Opin Support Palliat Care 2009; 3:252-7.
7. Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007; 167:2469-75.
8. Perrin-Terrin A, Pathak A, Lapeyre-Mestre M. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundam Clin Pharmacol 2010; 25:503-10.
9. Lamont P, Hunt SC. A twist on torsade: a prolonged QT interval on methadone. J Gen Intern Med 2006; 21:C9-C12.
10. Krantz MJ, Lowery CM, Martell BA, GourevitchMN, Arnsten JH. Effects of methadone on QT-interval dispersion. Pharmacotherapy 2005; 25:1523-9.
11. Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009; 104: 993-9.
12. Farrell M. Opiate withdrawal. Addiction 1994; 89:1471-5.
13. Leo RJ, Narendran R, DeGuiseppe B. Methadone detoxification of tramadol dependence. J Subst Abuse Treat 2000; 19:297-9.
14. Smith HS. Opioid metabolism. Mayo Clin Proc 2009; 84:613-24.
15. Gillen C, Haurand M, Kobelt DJ,Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 116-21.
16. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992; 105:147-51.
17. Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 1993; 108:806-11.
18. Bamigbade TA, Langford RM. Tramadol hydrochloride: an overview of current use. Hosp Med 1998; 59:373-6.
19. Ehrenreich H, Poser W. Dependence on tramadol. Clin Investig 1993; 72:76.
20. Miranda HF, Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav 1998; 61: 357-60.
21. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 1991; 27:7-17.
22. Tjaderborn M, Jonsson AK, Ahlner J, Hagg S. Tramadol dependence: a survey of spontaneously reported cases in Sweden. Pharmacoepidemiol Drug Saf 2009; 18: 1192-8.
23. Salehi M, Amanatkar M, Barekatain M. Efficacy of tramadol versus fentanyl for postoperative analgesia in neonates. Journal of Research in Medical Sciences 2006; 11: 185-189.
24. Tamaskar R, Parran TV Jr, Heggi A, Brateanu A, Rabb M, Yu J. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study. J Addict Dis 2003; 22:5-12.
25. Threlkeld M, Parran TV, Adelman CA, Grey SF, Yu J. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study. Am J Addict 2006; 15:186-91.
26. Sobey PW, Parran TV Jr, Grey SF, Adelman CL, Yu J. tramadol for acute heroin withdrawal: a comparison to clonidine. J Addict Dis 2003; 22:13-25.
27. Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987; 13:293-308.
28. Prosser JM, Steinfeld M, Cohen LJ, et al. Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadonemaintenance. Drug Alcohol Depend 2008; 95:237-44.
29. Shimoyama N, Shimoyama M, Elliott KJ, Inturrisi CE. d-Methadone is antinociceptive in the rat formalin test. J Pharmacol Exp Ther 1997; 283:648-52.
30. Volavka J, Verebey K, Resnick R, Mule S. Methadone dose, plasma level, and crosstolerance to heroin in man. J Nerv Ment Dis 1978; 166: 104-9.
31. Liu SJ, Wang RI. Effects of acute and chronic morphine treatment on methadone analgesia and metabolism. Eur J Pharmacol 1985; 109: 55-63.